Skip to content

Clinical trials

Phase 1/2 Hypoxia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoxia Phase: Phase 1/2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20122
20131
20141
20191
20201
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Colorado State University2
Threshold Pharmaceuticals2
Hunter Holmes Mcguire Veteran Affairs Medical Center1
Mallinckrodt1
NiKang Therapeutics, Inc.1
Reven Pharmaceuticals, Inc.1
Spaulding Rehabilitation Hospital1
Teclison Ltd.1
University of Colorado, Denver1
University of Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoxia12
COVID-192
Respiratory Distress Syndrome2
Acidosis, Respiratory1
Acute Lung Injury1
Altitude Sickness1
Carcinoma, Hepatocellular1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Kidney Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.